These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3030696)

  • 41. Circulating factors and insulin resistance. I. A novel myoinositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in noninsulin-dependent diabetes mellitus.
    Galasko GT; Bao Y; Broomfield SJ; Hooper NM; Turner AJ; Larner J
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2419-29. PubMed ID: 7629237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intracellular mediators of insulin action.
    Jarett L; Kiechle FL
    Vitam Horm; 1984; 41():51-78. PubMed ID: 6397911
    [No Abstract]   [Full Text] [Related]  

  • 43. Mechanism of action of insulin.
    DUNN A; ALTSZULER N; DE BODO RC; STEELE R; ARMSTRONG DT; BISHOP JS
    Nature; 1959 Apr; 183(4668):1123-4. PubMed ID: 13657022
    [No Abstract]   [Full Text] [Related]  

  • 44. [On the mechanism of action of insulin in the light of present-day data].
    KNIAZEV IuA
    Pediatriia; 1962 Dec; 41():74-8. PubMed ID: 14033746
    [No Abstract]   [Full Text] [Related]  

  • 45. The mechanism of action of insulin.
    WEIL-MALHERBE H
    Ergeb Physiol; 1955; 48():55-111. PubMed ID: 13330727
    [No Abstract]   [Full Text] [Related]  

  • 46. On the Mechanism of Insulin Action.
    Mueller EF; Wiener HJ
    Bull N Y Acad Med; 1925 Aug; 1(6):235-41. PubMed ID: 19311514
    [No Abstract]   [Full Text] [Related]  

  • 47. On the location and nature of the action of insulin.
    Burn JH; Dale HH
    J Physiol; 1924 Oct; 59(2-3):164-92. PubMed ID: 16993699
    [No Abstract]   [Full Text] [Related]  

  • 48. The Problem of the Fundamental Action of Insulin.
    Macleod JJ
    Can Med Assoc J; 1925 May; 15(5):476-8. PubMed ID: 20315359
    [No Abstract]   [Full Text] [Related]  

  • 49. Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells.
    Lin X; Ma L; Fitzgerald RL; Ostlund RE
    Arch Biochem Biophys; 2009 Jan; 481(2):197-201. PubMed ID: 19032932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide.
    Nascimento NR; Lessa LM; Kerntopf MR; Sousa CM; Alves RS; Queiroz MG; Price J; Heimark DB; Larner J; Du X; Brownlee M; Gow A; Davis C; Fonteles MC
    Proc Natl Acad Sci U S A; 2006 Jan; 103(1):218-23. PubMed ID: 16373499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-inositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells.
    Romero G; Gámez G; Huang LC; Lilley K; Luttrell L
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1476-80. PubMed ID: 2137614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dipyridamole stimulates types II cAMP-dependent protein kinase in vitro.
    Jiménez JS; Lechuga CG; Alonso G; Benítez MJ; Ros M; Moreno FJ
    Mol Cell Biochem; 1992 Jan; 109(1):9-15. PubMed ID: 1614423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of cytosolic-[Ca2+] oscillations in hepatocytes results from cross-talk among second messengers. The synergism between the alpha 1-adrenergic response, glucagon and cyclic AMP, and their antagonism by insulin and diacylglycerol manifest themselves in the control of the cytosolic-[Ca2+] oscillations.
    Somogyi R; Zhao M; Stucki JW
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):869-77. PubMed ID: 1329720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin and a putative insulin metabolic mediator fraction from liver and muscle stimulate p33 messenger ribonucleic acid accumulation by apparently different mechanisms.
    Sato T; Palasi CV; Huang L; Tang G; Larner AC; Larner J
    Endocrinology; 1988 Sep; 123(3):1559-64. PubMed ID: 3042371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purification and partial characterization of a putative mediator of insulin action on cyclic AMP-dependent protein kinase.
    Thompson MP; Larner J; Kilpatrick DL
    Mol Cell Biochem; 1984 Apr; 62(1):67-75. PubMed ID: 6377044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antilipolytic effects of insulin and adenylate cyclase inhibitors on isolated human fat cells.
    Lönnqvist F; Wennlund A; Arner P
    Int J Obes; 1989; 13(2):137-46. PubMed ID: 2545639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A putative mediator of insulin action which inhibits adenylate cyclase and adenosine 3',5'-monophosphate-dependent protein kinase: partial purification from rat liver: site and kinetic mechanism of action.
    Malchoff CD; Huang L; Gillespie N; Palasi CV; Schwartz CF; Cheng K; Hewlett EL; Larner J
    Endocrinology; 1987 Apr; 120(4):1327-37. PubMed ID: 3030696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of streptozotocin-induced diabetes on adenylate cyclase activity in cultured type II pneumocytes.
    Brown LA
    Am J Respir Cell Mol Biol; 1991 Feb; 4(2):108-14. PubMed ID: 1846745
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.